10 Biggest Price Target Changes For Friday - Chemours (NYSE:CC), BridgeBio Pharma (NASDAQ:BBIO)

Wedbush boosted the price target for Starbucks Corporation SBUX from $88 to $101. Starbucks shares rose 0.4% to $100.55 in pre-market trading.
Needham boosted Docusign Inc DOCU price target from $240 to $275. Docusign shares gained 5.2% to $243.05 in pre-market trading.
Stephens & Co. raised the price target on NCR Corporation NCR from $30 to $39. NCR shares rose 3.8% to close at $31.33 on Thursday.
Barclays lifted the price target for Chemours Co CC from $26 to $28. Chemours shares fell 0.4% to $25.58 in pre-market trading.
KeyBanc boosted the price target on Cooper Companies Inc COO from $349 to $367. Cooper Companies shares rose 0.1% to $338.00 in pre-market trading.
HC Wainwright & Co. raised TRACON Pharmaceuticals Inc TCON price target from $7 to $12. TRACON Pharmaceuticals shares fell 2.1% to close at $9.15 on Thursday.
SVB Leerink raised BridgeBio Pharma Inc BBIO price target from $39 to $44. BridgeBio Pharma shares rose 3.4% to close at $50.51 on Thursday.
Chardan Capital boosted the price target for Mesoblast limited MESO from $5.5 to $7.5. Mesoblast shares fell 6.3% to $14.75 in pre-market trading.
Mizuho lifted SAGE Therapeutics Inc SAGE price target from $77 to $81. SAGE Therapeutics shares rose 2.6% to $71.70 in pre-market trading.
KeyBanc lifted price target for Phreesia Inc PHR from $37 to $50. Phreesia shares rose 2.1% to close at $44.92 on Thursday.